News by Topic
News Archive
Drug Alerts
Recently Added
Top 10 Pages

Drug Approvals

A new medication used in the treatment of prostate cancer in certain patients was approved by the U.S. Food and Drug Administration (FDA) on April 29, 2010.

The medication, known...

On May 6, 2010, the Food and Drug Administration (FDA) approved Natazia (estradiol valerate/dienogest), a new type of combination birth...

A revised version of OxyContin intended to prevent abuse of the widely used opioid analgesic has now been approved by the U.S. Food and...

The U.S. Food and Drug Administration (FDA) is standing by its decision to approve diabetes drug Victoza (liraglutide), despite research...

The FDA has broadened the approved use of Crestor, a cholesterol-lowering medication typically used in patients with elevated levels of...

On January 29, 2010, the U.S. Food and Drug Administration approved the concurrent use of the oral drugs Tykerb (lapatinib) and Femara (...

The U.S. Food and Drug Administration approved Ampyra, a new medication intended to improve walking ability in individuals with multiple sclerosis, on January 22, 2010. In clinical...

The U.S. Food and Drug Administration (FDA) approved Actemra (tocilizumab) on January 8, 2010, for use in patients with cases of moderate to severe rheumatoid arthritis (RA) who have not...

A new injectable form of Eli Lilly & Co.’s top-selling drug Zyprexa received U.S. Food and Drug Administration (FDA) approval on December 14, 2009. The...

Wilate, a drug manufactured by Octapharma USA, was approved on December 8, 2009, by the U.S. Food and Drug Administration for the treatment of spontaneous and trauma-induced bleeding...

On December 4, 2009, Eli Lilly & Co. received Food and Drug Administration (FDA) approval for the marketing of Zyprexa for schizophrenia and manic depression...

On December 1, 2009, Dyax Corp. received Food and Drug Administration (FDA) approval for Kalbitor (ecallantide), the first injectable medication approved to treat all symptoms of...

The Agriflu vaccine was approved by the U.S. Food and Drug Administration (FDA) on November 27, 2009, for patients 18 years and older. Agriflu, manufactured by Novartis Vaccines and...

On November 30, 2009, Eli Lilly and Co. received Food and Drug Administration (FDA) approval for the antidepressant Cymbalta (duloxetine) to be used in the...

Lysteda tablets received approval by the United States Food and Drug Administration (FDA) on Friday, Nov. 13, 2009, to treat menorrhagia, a condition characterized by heavy menstrual...

CSL Limited’s 2009 H1NI flu vaccine was approved for children aged six months and older by the United States Food and Drug Administration (FDA) on November 12, 2009.

The vaccine...

The Food and Drug Administration (FDA) announced the approval of Istodax (romidepsin) on November 9, 2009. Istodax is a medication used in the treatment of cutaneous t-cell lymphoma (...

The United States Food and Drug Administration (FDA) approved Arzerra (ofatumumab) on October 26, 2009, for use in the treatment of chronic lymphocytic leukemia (CLL), a type of leukemia...

On Monday, October 19, 2009, the United States Food and Drug Administration (FDA) approved Votrient (pazopanib) for the treatment of kidney cancer.

Kidney cancer affects...

On Friday, October 16, 2009, the Food and Drug Administration (FDA) approved Merck & Co.’s Gardasil vaccine for use in boys and men, ages 9...

On October 9, 2009, the U.S. Food and Drug Administration (FDA) approved Berinert, the first medication available to treat facial swelling and acute abdominal attacks attributed to...

On Thursday, October 8, 2009, BioDelivery Sciences International, Inc. (BDSI) announced that its revolutionary new drug for cancer pain management, Onsolis, will hit the U.S. market next...

The Food and Drug Administration (FDA) announced the approval of the drug Folotyn (pralatrexate) September 25, 2009, as a treatment for peripheral T-cell lymphoma (PTCL), a typically...

The Food and Drug Administration (FDA) approved a new drug used in the treatment of moderate to severe psoriasis on September 25, 2009. The approval of Stelara (ustekinumad) occurred...

Drug News & Alerts
Subscribe to RSS